These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 34908570)
1. Tofacitinib as a novel therapy in COVID-19 acute respiratory distress syndrome. Panda R; Singh P; Kodamanchili S; Anand A Indian J Anaesth; 2021 Oct; 65(Suppl 4):S174-S176. PubMed ID: 34908570 [No Abstract] [Full Text] [Related]
2. [Therapy of coronavirus disease 2019 induced acute respiratory distress syndrome is different from traditional acute respiratory distress syndrome]. Pan C; Xie JF; Qiu HB; Yang Y Zhonghua Shao Shang Za Zhi; 2020 May; 36(5):330-333. PubMed ID: 32456368 [TBL] [Abstract][Full Text] [Related]
4. Remote ischemic conditioning for acute respiratory distress syndrome in COVID-19. Incognito AV; Millar PJ; Pyle WG Am J Physiol Lung Cell Mol Physiol; 2021 Mar; 320(3):L331-L338. PubMed ID: 33404365 [TBL] [Abstract][Full Text] [Related]
5. Acute Respiratory Distress Syndrome in a Patient With Acute Promyelocytic Leukemia: Overlapping Between Differentiation Syndrome and COVID-19. Sui J; Kelmenson D; Hu S; Cao L J Hematol; 2021 Oct; 10(5):217-220. PubMed ID: 34804311 [TBL] [Abstract][Full Text] [Related]
6. Prolonged Intermittent Renal Replacement Therapy for Acute Kidney Injury in COVID-19 Patients with Acute Respiratory Distress Syndrome. Ramirez-Sandoval JC; Gaytan-Arocha JE; Xolalpa-Chávez P; Mejia-Vilet JM; Arvizu-Hernandez M; Rivero-Sigarroa E; Torruco-Sotelo C; Correa-Rotter R; Vega-Vega O Blood Purif; 2021; 50(3):355-363. PubMed ID: 33105136 [TBL] [Abstract][Full Text] [Related]
7. Physical rehabilitation in Intensive Care Unit in acute respiratory distress syndrome patients with COVID-19. Ozyemisci Taskiran O; Turan Z; Tekin S; Senturk E; Topaloglu M; Yurdakul F; Ergonul O; Cakar N Eur J Phys Rehabil Med; 2021 Jun; 57(3):434-442. PubMed ID: 33448757 [TBL] [Abstract][Full Text] [Related]
8. Acute respiratory distress syndrome (ARDS) caused by the novel coronavirus disease (COVID-19): a practical comprehensive literature review. Montenegro F; Unigarro L; Paredes G; Moya T; Romero A; Torres L; López JC; González FEJ; Del Pozo G; López-Cortés A; Diaz AM; Vasconez E; Cevallos-Robalino D; Lister A; Ortiz-Prado E Expert Rev Respir Med; 2021 Feb; 15(2):183-195. PubMed ID: 32902367 [TBL] [Abstract][Full Text] [Related]
9. Mesenchymal stem cells as living anti-inflammatory therapy for COVID-19 related acute respiratory distress syndrome. Lin F; Ichim TE; Pingle S; Jones LD; Kesari S; Ashili S World J Stem Cells; 2020 Oct; 12(10):1067-1079. PubMed ID: 33178392 [TBL] [Abstract][Full Text] [Related]
10. Nitric oxide inhalation as an interventional rescue therapy for COVID-19-induced acute respiratory distress syndrome. Kobayashi J; Murata I Ann Intensive Care; 2020 May; 10(1):61. PubMed ID: 32436029 [TBL] [Abstract][Full Text] [Related]
11. A Case of Extracorporeal Membrane Oxygenation as a Salvage Therapy for COVID-19-Associated Severe Acute Respiratory Distress Syndrome: Mounting Evidence. Rajdev K; Farr LA; Saeed MA; Hooten R; Baus J; Boer B J Investig Med High Impact Case Rep; 2020; 8():2324709620957778. PubMed ID: 32911986 [TBL] [Abstract][Full Text] [Related]
12. Effects of Positive End-Expiratory Pressure in "High Compliance" Severe Acute Respiratory Syndrome Coronavirus 2 Acute Respiratory Distress Syndrome. Grasso S; Mirabella L; Murgolo F; Di Mussi R; Pisani L; Dalfino L; Spadaro S; Rauseo M; Lamanna A; Cinnella G Crit Care Med; 2020 Dec; 48(12):e1332-e1336. PubMed ID: 32932346 [TBL] [Abstract][Full Text] [Related]
13. Role of monoclonal antibody drugs in the treatment of COVID-19. Ucciferri C; Vecchiet J; Falasca K World J Clin Cases; 2020 Oct; 8(19):4280-4285. PubMed ID: 33083387 [TBL] [Abstract][Full Text] [Related]
14. Follow-up strategy with long-term veno-venous extracorporeal membrane oxygenation support for complicated severe acute respiratory distress related to COVID-19 and recovery of the lungs. Kırali K; Erkılınç A; Erdal Taşçı A; Mert Özgür M; Gecmen G; Altınay E; Oğuş H; Vayvada M Turk Gogus Kalp Damar Cerrahisi Derg; 2021 Apr; 29(2):252-258. PubMed ID: 34104520 [TBL] [Abstract][Full Text] [Related]
15. Use of Cannabinoids to Treat Acute Respiratory Distress Syndrome and Cytokine Storm Associated with Coronavirus Disease-2019. Nagarkatti P; Miranda K; Nagarkatti M Front Pharmacol; 2020; 11():589438. PubMed ID: 33240092 [TBL] [Abstract][Full Text] [Related]
16. Extracorporeal membrane oxygenation for coronavirus disease 2019-associated acute respiratory distress syndrome: Report of two cases and review of the literature. Wen JL; Sun QZ; Cheng Z; Liao XZ; Wang LQ; Yuan Y; Li JW; Hou LS; Gao WJ; Wang WJ; Soh WY; Li BF; Ma DQ World J Clin Cases; 2021 Mar; 9(8):1953-1967. PubMed ID: 33748247 [TBL] [Abstract][Full Text] [Related]
17. Lung Mechanics in COVID-19 Resemble Respiratory Distress Syndrome, Not Acute Respiratory Distress Syndrome: Could Surfactant Be a Treatment? Koumbourlis AC; Motoyama EK Am J Respir Crit Care Med; 2020 Aug; 202(4):624-626. PubMed ID: 32579022 [No Abstract] [Full Text] [Related]
18. The rationale of using mesenchymal stem cells in patients with COVID-19-related acute respiratory distress syndrome: What to expect. Can A; Coskun H Stem Cells Transl Med; 2020 Nov; 9(11):1287-1302. PubMed ID: 32779878 [TBL] [Abstract][Full Text] [Related]
19. Prone positioning for patients intubated for severe acute respiratory distress syndrome (ARDS) secondary to COVID-19: a retrospective observational cohort study. Weiss TT; Cerda F; Scott JB; Kaur R; Sungurlu S; Mirza SH; Alolaiwat AA; Kaur R; Augustynovich AE; Li J Br J Anaesth; 2021 Jan; 126(1):48-55. PubMed ID: 33158500 [TBL] [Abstract][Full Text] [Related]
20. Human and novel coronavirus infections in children: a review. Rajapakse N; Dixit D Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]